Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia. Choo YW, Mohd Tahir NA, Mohamed Said MS, Li SC, et al. Osteoporos Int 2022 May 31. pii: 10.1007/s00198-022-06444.

Read + Share

Amedeo Smart

Independent Medical Education

Choo YW, Mohd Tahir NA, Mohamed Said MS, Li SC, et al. Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia. Osteoporos Int 2022 May 31. pii: 10.1007/s00198-022-06444.
PMID: 35641572